Market Share of Skin Cancer Therapeutics Industry
The global skin cancer therapeutics market is highly competitive and consists of several major players. The competition in the market is due to factors such as rising launches and approvals of skin cancer therapeutics and increased R&D for developing novel skin cancer therapeutics. Some of the companies operating in the market include Amgen, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, and Sanofi SA, among others,
Skin Cancer Diagnostics & Therapeutics Market Leaders
Amgen Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd.
Sanofi SA
*Disclaimer: Major Players sorted in no particular order
